Literature DB >> 22020605

Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: a case report.

Christopher L Anderson1, M Camden Whitaker.   

Abstract

STUDY
DESIGN: A case of heterotopic ossification in the lumbar spine associated with the off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) is reported.
OBJECTIVE: To highlight a previously unreported complication of rhBMP-2 use and to review the literature pertinent to the topic. SUMMARY OF BACKGROUND DATA: There is no report in the literature regarding a large mass of rhBMP-2-associated heterotopic ossification surrounding the paraspinal musculature.
METHODS: The clinical and radiographical features of this complication and treatment course are presented.
RESULTS: The surgical excision of heterotopic ossification and removal of symptomatic instrumentation have resulted in the patient remaining asymptomatic at 1 year of follow-up examination.
CONCLUSION: The reported case adds to the literature of off-label use of rhBMP-2 and the potential for the formation of heterotopic ossification with its use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22020605     DOI: 10.1097/BRS.0b013e318238870b

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  14 in total

1.  Recombinant human BMP-2 increases the incidence and rate of healing in complex ankle arthrodesis.

Authors:  Mitchell S Fourman; Eugene W Borst; Eric Bogner; S Robert Rozbruch; Austin T Fragomen
Journal:  Clin Orthop Relat Res       Date:  2013-08-29       Impact factor: 4.176

2.  Bone morphogenetic protein and orthopaedic surgery: can we legitimate its off-label use?

Authors:  Aurélien Courvoisier; Frederic Sailhan; Olivier Laffenêtre; Laurent Obert
Journal:  Int Orthop       Date:  2014-09-30       Impact factor: 3.075

3.  Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications.

Authors:  Sangheon Han; Trevor R Ham; Salma Haque; Jessica L Sparks; Justin M Saul
Journal:  Acta Biomater       Date:  2015-05-18       Impact factor: 8.947

4.  Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery.

Authors:  Raymond Wing Moon Lam; Sunny Akogwu Abbah; Wang Ming; Mathanapriya Naidu; Felly Ng; Hu Tao; James Goh Cho Hong; Kang Ting; Wong Hee Kit
Journal:  J Vis Exp       Date:  2016-08-22       Impact factor: 1.355

Review 5.  Complex ankle arthrodesis: Review of the literature.

Authors:  Remy V Rabinovich; Amgad M Haleem; S Robert Rozbruch
Journal:  World J Orthop       Date:  2015-09-18

6.  Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2.

Authors:  Sangeeta Subramanian; Ashley Mitchell; Weiling Yu; Sabrina Snyder; Kathryn Uhrich; J Patrick O'Connor
Journal:  Tissue Eng Part A       Date:  2015-04-29       Impact factor: 3.845

7.  Enhanced control of in vivo bone formation with surface functionalized alginate microbeads incorporating heparin and human bone morphogenetic protein-2.

Authors:  Sunny Akogwu Abbah; Jing Liu; James Cho Hong Goh; Hee-Kit Wong
Journal:  Tissue Eng Part A       Date:  2012-11-07       Impact factor: 3.845

8.  Sustained delivery of rhBMP-2 by means of poly(lactic-co-glycolic acid) microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis.

Authors:  Jason D Wink; Patrick A Gerety; Rami D Sherif; Youngshin Lim; Nadya A Clarke; Chamith S Rajapakse; Hyun-Duck Nah; Jesse A Taylor
Journal:  Plast Reconstr Surg       Date:  2014-07       Impact factor: 4.730

9.  Rare complications of osteolysis and periprosthetic tissue reactions after hybrid and non-hybrid total disc replacement.

Authors:  Sai Y Veruva; Todd H Lanman; Josa A Hanzlik; Steven M Kurtz; Marla J Steinbeck
Journal:  Eur Spine J       Date:  2014-08-28       Impact factor: 3.134

10.  Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4.

Authors:  Yasuyuki Shiozaki; Takashi Kitajima; Tetsuro Mazaki; Aki Yoshida; Masato Tanaka; Akihiro Umezawa; Mariko Nakamura; Yasuhiro Yoshida; Yoshihiro Ito; Toshifumi Ozaki; Akihiro Matsukawa
Journal:  Int J Nanomedicine       Date:  2013-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.